Clinical CareTexas Medicaid Recovers $110M from AstraZeneca
The off-label marketing for antipsychotic drugs allegedly occurred while AstraZeneca was already under a 2010 federal corporate integrity agreement for...
Clinical CareHow to Use Healthcare IT to Avoid Diagnostic and Medication Mix-Ups
Recommendations fall into three categories: communication, tracking, and acknowledgement of an information review and associated actions.
StrategyDéjà Voodoo: Pharma's Promises To Curb Drug Prices Have Been Heard Before
History suggests that pharmaceutical companies promise price restraints only as long as politically necessary.
FinanceAzar: Drug Importation May Not Be a Gimmick After All
There may be 'safe, select avenues for importation' that the U.S. government should consider, the HHS secretary said.
FinanceFDA Biosimilar Action Plan Aims for Affordability Through Competition
Commissioner Scott Gottlieb advocated for the plan during a Brookings Institution presentation.